Antimicrobial activity of ruthenium-based intercalators

Area of Science:

• Medicinal Chemistry
• Antimicrobial Research
• Drug Discovery

Background:

• Multidrug resistance in bacterial pathogens presents a significant global health challenge.
• There is an urgent need for novel antimicrobial agents with unique mechanisms of action.

Purpose of the Study:

• To investigate the antimicrobial potential of ruthenium(II)-based DNA-intercalating complexes.
• To evaluate the efficacy and toxicity of these novel compounds against bacterial pathogens.

Main Methods:

• In vitro antimicrobial assays were performed against Gram-positive (Bacillus subtilis, Staphylococcus aureus) and Gram-negative (Escherichia coli) bacteria.
• In vivo efficacy and toxicity were assessed using a Caenorhabditis elegans infection model.

Main Results:

• Ruthenium(II) complexes exhibited significant activity against Gram-positive bacteria.
• No in vitro activity was observed against the Gram-negative bacterium Escherichia coli.
• One compound showed in vivo antimicrobial activity in C. elegans without causing toxicity.

Conclusions:

• Ruthenium(II)-based DNA-intercalating complexes represent a promising class of compounds for combating Gram-positive bacterial infections.
• Further development of these complexes could lead to new therapeutic strategies against antibiotic-resistant bacteria.